Some Children with COVID-19 or MIS-C Face Kidney Injury: Study

The link between SARS-CoV-2 and potential stress to kidneys is unclear, but damage to the organs has been documented in adults with COVID-19 too.

Written byMarcus A. Banks
| 3 min read
kidney acute kidney injury covid-19 mis-c children kids nephrology long covid pandemic coronavirus sars-cov-2

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, BEASTFROMEAST

More than 10 percent of children hospitalized with COVID-19 or multisystem inflammatory syndrome, an inflammatory condition commonly known as MIS-C that in rare cases has followed SARS-CoV-2 infection, experienced acute kidney injury, according to a study published March 3 in Kidney International. Kids with kidney damage remained in the hospital an average of eight days longer than did other children facing these conditions without the added kidney stress.

“Recognizing that kidney function contributes to outcomes post-COVID is important to think about, especially in the pediatric population. These kids are young and have a whole life ahead of them,” says Abby Basalely, a pediatric nephrologist at Cohen Children’s Medical Center in New Hyde Park, New York, and a coauthor of the study.

People with acute kidney injury can have trouble regulating body fluids or urinating normally. The injury often resolves itself but will sometimes progress into chronic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • marcus a. banks

    Marcus is a science and health journalist based in New York City. He graduated from the Science Health and Environmental Reporting Program at New York University in 2019, and earned a master’s in Library and Information Science from Dominican University in 2002. He’s written for Slate, Undark, Spectrum, and Cancer Today.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies